Table 3.
Characteristics of Receiving Versus Not Receiving Kidney Failure Treatment Modality Education
Characteristic | All Enrolled Patients (N = 117) | Kidney Failure Treatment Modality Education |
||
---|---|---|---|---|
Received (n = 33) | Not Received (n = 84) | Pa | ||
Age, y | 71 [60-80] | 71 [59-79] | 70 [61-80] | 0.73 |
Female sex | 50 (43%) | 10 (30%) | 40 (48%) | 0.08 |
eGFR, mL/min/1.73 m2 | 21.4 [16.6-25.7] | 22.3 [16.6-25.7] | 20.9 [16.6-25.5] | 0.81 |
KFRE score | 0.16 [0.10-0.28] | 0.17 [0.08-0.29] | 0.16 [0.10-0.28] | 0.95 |
Charlson Comorbidity Index score | 6 [4-7] | 5 [3-6] | 6 [4-8] | 0.01 |
Diabetes | 83 (71%) | 22 (67%) | 61 (73%) | 0.52 |
Cardiovascular disease | 65 (56%) | 65 (56%) | 79 (63%) | 0.26 |
Time on registry as of June 30, 2018 | 8 [8-9] | 9 [9-10] | 8 [8,9] | 0.05 |
1-3 mo | 2 (1.7%) | 0 (0.0%) | 2 (2.4%) | |
4-6 mo | 12 (10.3%) | 4 (12.1%) | 8 (9.5%) | 0.29 |
7-9 mo | 79 (67.5%) | 19 (57.6%) | 60 (71.4%) | |
10-12 mo | 24 (20.5%) | 10 (30.3%) | 14 (16.7%) | |
Time enrolled as of June 30, 2018 | 6 [4-9] | 8 [5-9] | 6 [3-8] | 0.02 |
1-3 mo | 25 (21.4%) | 3 (9.1%) | 22 (26.2%) | |
4-6 mo | 34 (29.1%) | 11 (33.3%) | 23 (27.4%) | 0.03 |
7-9 mo | 43 (36.8%) | 11 (33.3%) | 32 (38.1%) | |
10-12 mo | 15 (12.8%) | 8 (24.2%) | 7 (8.3%) | |
Years in nephrology | 3 [1-6] | 3 [1-6] | 4 [1-7] | 0.69 |
Note: Values expressed as median [interquartile range] or number (percent).
Abbreviations: eGFR, estimated glomerular filtration rate; KFRE, Kidney Failure Risk Equation.
Chi-square tests for categorical measures and Kruskal-Wallis tests for continuous measures.